This trial will develop a communication-based intervention to improve understanding of Alzheimer's Disease, engagement in advance care planning, and receipt of goal-concordant care at the end-of-life.
6 Primary · 6 Secondary · Reporting Duration: Baseline, Post-Intervention (within 2 weeks), 3-month follow up
90 Total Participants · 1 Treatment Group
Primary Treatment: KNOW · No Placebo Group · N/A
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: